These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monitoring the therapeutic efficacy of CA4P in the rabbit VX2 liver tumor using dynamic contrast-enhanced MRI. Han T, Duan Q, Yang R, Wang Y, Yin H, Meng F, Liu Y, Qian T. Diagn Interv Radiol; 2021 Sep; 27(5):587-594. PubMed ID: 34559047 [Abstract] [Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model. Qian T, Chen M, Gao F, Meng F, Gao X, Yin H. Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024 [Abstract] [Full Text] [Related]
4. Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model. Moon J, Kim JH, Choi D, Yang J, Lee MW, Choi YL, Rhim H. J Appl Clin Med Phys; 2016 Sep 08; 17(5):418-427. PubMed ID: 27685133 [Abstract] [Full Text] [Related]
5. Correlation between Contrast-Enhanced Ultrasound and Microvessel Density via CD31 and CD34 in a rabbit VX2 lung peripheral tumor model. Xing J, He W, Ding YW, Li Y, Li YD. Med Ultrason; 2018 Feb 04; 1(1):37-42. PubMed ID: 29400366 [Abstract] [Full Text] [Related]
6. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters. Othman AE, Falkner F, Martirosian P, Schraml C, Schwentner C, Nickel D, Nikolaou K, Notohamiprodjo M. Invest Radiol; 2016 Feb 04; 51(2):106-12. PubMed ID: 26447494 [Abstract] [Full Text] [Related]
7. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist. Zhang Y, Liu H, Xiao W, Zhu L, Wang N, He X, Jiang Z, Guan B. BJR Case Rep; 2017 Feb 04; 3(3):20160099. PubMed ID: 30363268 [Abstract] [Full Text] [Related]
8. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results. Yeo DM, Oh SN, Jung CK, Lee MA, Oh ST, Rha SE, Jung SE, Byun JY, Gall P, Son Y. J Magn Reson Imaging; 2015 Feb 04; 41(2):474-80. PubMed ID: 24375840 [Abstract] [Full Text] [Related]
9. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model. Wu L, Lv P, Zhang H, Fu C, Yao X, Wang C, Zeng M, Li Y, Wang X. Magn Reson Imaging; 2015 Jul 04; 33(6):737-60. PubMed ID: 25169584 [Abstract] [Full Text] [Related]
10. Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis. Kim SH, Lee HS, Kang BJ, Song BJ, Kim HB, Lee H, Jin MS, Lee A. PLoS One; 2016 Jul 04; 11(12):e0168632. PubMed ID: 28036342 [Abstract] [Full Text] [Related]
11. In vivo assessment of the vascular disrupting effect of M410 by DCE-MRI biomarker in a rabbit model of liver tumor. Yang RM, Zou Y, Huang DP, Lai SS, Xu XD, Wei XH, Chang HZ, Huang TK, Wang L, Tang WJ, Jiang XQ. Oncol Rep; 2014 Aug 04; 32(2):709-15. PubMed ID: 24898785 [Abstract] [Full Text] [Related]
12. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma. Song KD, Choi D, Lee JH, Im GH, Yang J, Kim JH, Lee WJ. AJR Am J Roentgenol; 2014 Jun 04; 202(6):W559-66. PubMed ID: 24848850 [Abstract] [Full Text] [Related]
13. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model. Ahn SJ, An CS, Koom WS, Song HT, Suh JS. Korean J Radiol; 2011 Jun 04; 12(6):722-30. PubMed ID: 22043155 [Abstract] [Full Text] [Related]
14. Comparison of semi-quantitative and quantitative dynamic contrast-enhanced MRI evaluations of vertebral marrow perfusion in a rat osteoporosis model. Zhu J, Xiong Z, Zhang J, Qiu Y, Hua T, Tang G. BMC Musculoskelet Disord; 2017 Nov 14; 18(1):446. PubMed ID: 29137612 [Abstract] [Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy. Ren Z, Feng G, Li B, Zhang C, Du Y. Sci Rep; 2024 Feb 24; 14(1):4557. PubMed ID: 38402352 [Abstract] [Full Text] [Related]
16. Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Zhang Y, Kapur P, Yuan Q, Xi Y, Carvo I, Signoretti S, Dimitrov I, Cadeddu JA, Margulis V, Muradyan N, Brugarolas J, Madhuranthakam AJ, Pedrosa I. Clin Genitourin Cancer; 2016 Feb 24; 14(1):e25-36. PubMed ID: 26422014 [Abstract] [Full Text] [Related]
17. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors. Jia WR, Chai WM, Tang L, Wang Y, Fei XC, Han BS, Chen M. Eur J Radiol; 2014 Jul 24; 83(7):1098-1105. PubMed ID: 24794865 [Abstract] [Full Text] [Related]
18. Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: Correlations with dominant stroma type. Yim H, Kang DK, Jung YS, Jeon GS, Kim TH. Magn Reson Imaging; 2016 Jan 24; 34(1):60-5. PubMed ID: 26234500 [Abstract] [Full Text] [Related]